MCT2D Resource: Dosing Information for SGLT-2 Inhibitors and GLP-1 Receptor Agonists for Type 2 Diabetes

Updated: 10/16/23

Key dosing information for SGLT2-I and GLP1-RAs including dose escalation, pen and needle RX considerations, proven benefits for ASCVD, CKD, HFrEF, HFpEF, and DKD.

Tags: For Providers, Created By MCT2D, Point-of-care

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!